Human Herpesvirus 6 (HHV-6) Antibodies, IgG
Also known as: HHV-6, IgG Antibodies
Use
Aid in the diagnosis of past infection/exposure to roseola infantum; may be useful in diagnosis of chronic fatigue syndrome
Special Instructions
Please note that nucleic acid amplification (PCR) is the recommended testing method for diagnosis of active HHV-6 infection.
Limitations
This procedure may be considered by Medicare and other carriers as investigational, and therefore, may not be payable as a covered benefit for patients. The results of this test are labeled for research purposes only by the assay's manufacturer. Performance characteristics of this assay have not been established by the manufacturer and the result should not be used for treatment or diagnostic purposes without confirmation of the diagnosis by another medically established diagnostic product or procedure. Performance characteristics were determined by LabCorp.
Methodology
Immunoassay (EIA)
Biomarkers
LOINC Codes
- 41148-8
- 41148-8
Result Turnaround Time
2-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
If tube other than a gel-barrier tube is used, transfer separated serum to a plastic transport tube. Do not freeze gel-barrier tube (pour off serum first).
Storage Instructions
Room temperature
Causes for Rejection
Hemolysis; lipemia; gross bacterial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |